ArticleJournal of nanobiotechnology2026
Super-resolution mapping reveals NAD⁺-delivering probiotic extracellular vesicles as nanotherapeutics for organelle protection and inflammation control.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bacterial Extracellular Vesicles in Aging: Mechanisms and Therapeutic Prospects.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundLactobacillus plantarum (L. plantarum) is a probiotic bacterium with diverse health-promoting effects. Recent evidence suggests that these benefits are mediated by extracellular vesicles (EVs) secreted by the bacterium; however, the underlying molecular mechanisms in the context of pathogenic inflammation remain poorly understood.
resultsIn this study, we employed super-resolution stochastic optical reconstruction microscopy to elucidate the molecular mechanisms of action of L. plantarum EVs by monitoring alterations in the ultrastructural integrity of cellular organelles in human dermal fibroblasts exposed to Staphylococcus aureus EVs. Pathogenic EV exposure induced characteristic inflammatory changes in organelle morphology. Remarkably, both pre- and post-treatment with L. plantarum EVs restored organelle morphology in a concentration- and time-dependent manner. Cytokine profiling showed selective suppression of interleukin (IL)-6 and IL-8 while preserving IL-10, indicating targeted immunomodulation. We identified nicotinamide adenine dinucleotide (NAD⁺) as a key bioactive cargo, with exogenous NAD⁺ treatment reproducing both structural and cytokine-restorative effects.
conclusionsThese findings establish NAD⁺-mediated organelle protection as a central mechanism through which probiotic EVs mitigate bacterial inflammation. By linking organelle integrity to inflammatory outcomes, our study highlights L. plantarum EVs as nanoscale therapeutic candidates for infection-driven inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.